|
Ezetimibe Impurity 118
|
N-Cyanonorbuprenorphine
|
799773-67-4
|
|
Simvastatin Impurity 31
|
|
16614-59-8
|
|
Simvastatin Impurity 30
|
10-Oxo Buprenorphine
|
1044710-08-8
|
|
Cefatrizine Propylene Glycol Impurity 1(Cefatrizine Propylene Glycol EP Impurity A)
|
5-((Z)-(5-氟-2-氧代吲哚烷-3-亞基)甲基)-2,4-二甲基-1H-吡咯-3-羧酸
|
356068-93-4
|
|
Folic Acid Impurity 46
|
Clobetasone Butyrate EP Impurity C
|
639817-49-5
|
|
Sunitinib Impurity 75
|
雙丙戊酸鈉雜質(zhì)07
|
5699-52-5
|
|
*Buprenorphine Impurity 19
|
瑞舒伐他汀雜質(zhì)
|
854898-53-6
|
|
Sulfamethoxazole Impurity 18
|
雷洛昔芬二聚體
|
618902-12-8
|
|
Sulfamethoxazole Impurity 20
|
RALOXIFENE4-MONOMETHYLETHER
|
185415-07-0
|
|
Chymotrypsin
|
1222490-34-7
|
1222490-34-7
|
|
Buprenorphine Impurity 12
|
|
116649-86-6
|
|
Sulfamic Acid Impurity 9
|
6-TERT-BUTYLDIMETHYLSILYL-4'-HYDROXYRALOXIFENE-D4
|
1329611-25-7
|
|
Buprenorphine Impurity 20
|
2,2,14,14-四甲基-8-氧代-十五烷二酸二乙酯
|
738606-43-4
|
|
Ranolazine Impurity 19
|
917389-29-8
|
917389-29-8
|
|
Diclazuril Impurity8 (Diclazuril EP ImpurityH)
|
P-HYDROXYCOCAINE HYDROCHLORIDE SOLUTION
|
197771-77-0
|
|
Diclazuril Impurity5 (Diclazuril EP ImpurityE)
|
3-(對氟苯甲酰氧基)托烷
|
172883-97-5
|
|
Drotaverine Impurity 11
|
42-O-[2-[[羥基[2-(三甲基銨基)乙氧基]亞膦酰]氧基]乙基]雷帕霉素內(nèi)鹽
|
1062645-51-5
|
|
Loperamide Impurity 9
|
N-Cyano-3-[(ethoxycarbonyl)oxy]-norbuprenorphine
|
1465923-74-3
|
|
Esomeprazole Impurity 145
|
|
130668-49-4
|
|
Carmustine Impurity 1 (Carmustine EP Impurity A)
|
N-Boc-N,N-didesethyl Sunitinib
|
1227960-76-0
|
|
Clobetasone Butyrate Impurity 4 (Clobetasone Butyrate EP Impurity D)
|
N-(2,6-二甲基苯基)-4-[2-羥基-3-[2-(三氘甲基)苯氧基]丙基]-1-哌嗪乙酰胺
|
1054624-77-9
|
|
Sunitinib Impurity 68
|
3-氨基-4-氯苯甲酸
|
2840-28-0
|
|
Sulfamic Acid Impurity 8
|
RALOXIFENE-D4 BISMETHYL ETHER
|
1185006-58-9
|
|
Cetirizine Impurity 10 Monomer（Cetirizine EP Impurity B Monomer）
|
屈他維林雜質(zhì)11
|
121280-59-9
|
|
Phloroglucinol Impurity 48 Monomer
|
Raloxifene 6,4Bis-b-D-glucuronide
|
182507-20-6
|
|
Chelerythrine Impurity2
|
|
99487-86-2
|
|
Sofosbuvir Impurity 137
|
Delafloxacin Impurity 5
|
2097714-09-3
|
|
Simvastatin Impurity 45
|
Clobetasone Butyrate EP Impurity F
|
25120-98-3
|
|
Simvastatin Impurity 47
|
Clobetasone Butyrate EP Impurity I
|
639817-47-3
|
|
Sulfamethoxazole-13C6
|
|
174264-47-2
|
|
Buprenorphine Impurity 15
|
6-胍基己酸鹽酸鹽
|
6659-35-4
|
|
Buprenorphine Impurity 18
|
7-[4-(4-氟苯基)-6-異丙基-2-(甲基-甲磺酰-氨基)-嘧啶-5-基]-3,5-二羥基庚-6-烯酸
|
854898-48-9
|
|
Diclazuril Impurity3 (Diclazuril EP ImpurityC)
|
間羥基可卡因
|
71387-58-1
|
|
Clobetasone Butyrate Impurity 9 (Clobetasone Butyrate EP Impurity I)
|
42-O-[(1,1-Dimethylethyl)dimethylsilyl]rapamycin
|
143030-02-8
|
|
Indacaterol Impurity 57
|
5-(BENZYLOXY)RESORCINOL
|
59291-87-1
|
|
Simvastatin Impurity 33
|
XIROWXSHVUJQLM-DHCTZRPISA-N
|
90387-35-2
|
|
Moxifloxacin Impurity 9 Monomer
|
六氫噠嗪-3-羧酸
|
32750-52-0
|
|
Carmustine
|
N-Boc-N-desethyl Sunitinib-d5
|
1246832-84-7
|
|
Clobetasone Butyrate
|
DesMethyl Ranolazine-d5
|
1329834-18-5
|
|
Clobetasone Butyrate Impurity 6 (Clobetasone Butyrate EP Impurity F)
|
DESMETHOXYRANOLAZINE-D5
|
1794788-57-0
|
|
Simvastatin Impurity 44
|
丁酸氯倍他松
|
25122-57-0
|
|
Pemetrexed Impurity 68
|
氯倍他松
|
54063-32-0
|
|
Ammuxetine Impurity 33
|
Clobetasone Butyrate EP Impurity E
|
639817-48-4
|
|
Mepivacaine Impurity 11
|
雷洛昔芬-4' -葡萄糖醛酸苷
|
182507-22-8
|
|
*Buprenorphine Impurity 14
|
RAC RAMELTEON-D3
|
1185146-24-0
|
|
Clazuril Impurity1 (Clazuril EP ImpurityA)
|
2-疊氮乙胺鹽酸鹽,2-AZIDOETHANAMINE HCL
|
118508-67-1
|
|
Oxaliplatin Impurity 9
|
|
185416-01-7
|
|
Sulfasalazine Impurity 29
|
6-Raloxifene-β-D-glucopyranoside
|
334758-18-8
|
|
Sulfamethoxazole Impurity 19
|
4,6-DI(TERT-BUTYLDIMETHYLSILY)RALOXIFENE
|
182249-24-7
|
|
Nintedanib Esylate
|
尼達(dá)尼布乙基磺酸鹽
|
656247-18-6
|
|
Diclazuril Impurity10
|
2-(芐氧基)乙腈
|
13620-31-0
|
|
Chelerythrine Impurity1
|
|
177795-60-7
|
|
*Lercanidipine Impurity 53
|
(3R,5R,6E)-7-[2-環(huán)丙基-4-(4-氟苯基)-3-喹啉基]-3,5-二羥基-6-庚烯酸
|
769908-13-6
|
|
Cinacalcet Impurity 101
|
舒尼替尼雜質(zhì)4
|
2377533-90-7
|
|
1,1,2-trichloro-1,2,2-trimethyldisilane
|
O-METHYL 7-(S)-BUPRENORPHINE
|
213404-55-8
|
|
Carmustine Impurity 2 (Carmustine EP Impurity B)
|
|
2417674-05-4
|
|
Clobetasone Butyrate Impurity 5 (Clobetasone Butyrate EP Impurity E)
|
Ranolazine-d8
|
1092804-88-0
|
|
Uracil Impurity 14
|
OPC-532135
|
1541171-68-9
|
|
Nintedanib Impurity 156
|
尼達(dá)尼布雜質(zhì)156
|
40872-87-5
|
|
*Buprenorphine Impurity 17
|
(3S,5R)-瑞舒伐他汀
|
1242184-42-4
|
|
Sulfamic Acid Impurity 6
|
|
174264-46-1
|
|
Simvastatin Impurity 46
|
CLOBETASONE 17 PROPIONATE
|
25122-56-9
|
|
*Chlorobutanol Impurity1 (Chlorobutanol EP ImpurityA)(Chloroform)
|
Α-毒傘肽
|
23109-05-9
|
|
Diclazuril Impurity4 (Diclazuril EP ImpurityD)
|
IQXBUEUAOWARGT-FIBGUPNXSA-N
|
253775-19-8
|
|
Sulpiride Impurity 31
|
Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-β-D-glycopyranuronate)
|
174264-51-8
|
|
Chelidonine Impurity2
|
酞丁安
|
210165-00-7
|
|
*Chlorobutanol Impurity2 (Chlorobutanol EP ImpurityB)(Acetone)
|
(S)-8-hydroxy-7-methoxy-2-methylene-2,3-dihydro-1H-benzo[e]-pyrrolo[1,2-a][1,4]diazepin-5(11aH)-one
|
945490-09-5
|
|
Lactic Acid Impurity 11
|
雷馬曲班
|
116649-85-5
|
|
Sofosbuvir Impurity 138
|
氟比洛芬酯
|
91503-79-6
|
|
Simvastatin Impurity 32
|
|
16196-70-6
|
|
Baricitinib Impurity 43
|
|
1246833-23-7
|
|
Cefapirin Impurity 2(Cefapirin EP Impurity A)
|
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl-
|
2170562-55-5
|
|
Clerosterol Impurity 2 (Gramisterol)
|
N,N-Didesethyl Sunitinib Hydrochloride
|
873077-70-4
|
|
Eptifibatide Impurity 16
|
雙丙戊酸鈉雜質(zhì)09
|
1824382-99-1
|
|
Ammuxetine Impurity 22
|
Clobetasone Butyrate EP Impurity D
|
639817-51-9
|
|
Sunitinib Impurity 74
|
雙丙戊酸鈉雜質(zhì)06
|
130000-32-7
|
|
Sulfamic Acid Impurity 10
|
4'-tert-ButyldiMethylsilyl-6-hydroxy Raloxifene-d4
|
1189422-34-1
|
|
Chelerythrine
|
(S)-Rabeprazole
|
177795-59-4
|
|
Buprenorphine Impurity 22
|
N-甲基-四氫呋喃-3-胺
|
89487-67-2
|
|
Diclazuril Impurity7 (Diclazuril EP ImpurityG)
|
|
50763-21-8
|
|
Diclazuril Impurity9 (Diclazuril EP ImpurityI)
|
JXRRURSUEBIBGP-UHFFFAOYSA-N
|
183793-33-1
|
|
Sulfamic Acid Impurity 7
|
雷洛昔芬二甲氧基雜質(zhì)
|
84541-38-8
|
|
Ceftriaxone Impurity 12 Dihydrate
|
RALOXIFENE6-MONOMETHYLETHER
|
178451-13-3
|
|
Buprenorphine Impurity 13
|
Ramelteon Metabolite M-II-d3 (mixture of R and S at the hydroxy position)
|
1246812-22-5
|
|
Cineole Impurity1 (Cineole EP ImpurityA)
|
2-(4-氨基-2-氯-5-甲基苯基)-2-(4-氯苯基)乙腈
|
61437-85-2
|
|
Letermovir Impurity 2
|
|
1356839-88-7
|
|
*Cocaine Hydrochloride Impurity 4
|
倍他米松戊酸酯
|
2152-44-5
|
|
Flumazenil Impurity 22
|
2-氯-1,3-苯二酚
|
6201-65-6
|
|
Closantel Sodium Impurity 2 (Closantel Sodium EP Impurity B)
|
1-(叔丁氧羰基)-2-吡咯烷酮
|
85909-08-6
|
|
Cocaine Hydrochloride Impurity 3(Cocaine Hydrochloride EP Impurity C )(β-Truxilline)
|
鹽酸貝尼地平
|
91599-74-5
|
|
Estradiol Impurity 14
|
|
183986-70-1
|
|
Tribenoside Impurity 6
|
羥基百菌清
|
28343-61-5
|
|
Carmustine Impurity 5
|
阿齊沙坦中間體V
|
2133408-92-9
|
|
Cocaine Hydrochloride Impurity 10
|
百菌清
|
1897-45-6
|
|
Flumazenil Impurity 21
|
4-乙基間苯二酚
|
2896-60-8
|
|
*Cocaine Hydrochloride
|
|
1397836-43-9
|
|
Closantel Sodium Impurity 1 (Closantel Sodium EP Impurity A)
|
N-芐基吡咯烷酮
|
5291-77-0
|
|
Betamethasone Valerate EP Impurity F
|
戊酸倍他米松EP雜質(zhì)F
|
16125-28-3
|
|
Closantel Sodium Impurity 6 (Closantel Sodium EP Impurity F)
|
雙三甲基硅基胺基鋰
|
4039-32-1
|
|
Cocaine Hydrochloride Impurity 2(Cocaine Hydrochloride EP Impurity B )(α-Truxilline)
|
甲磺酸雙氫麥角堿
|
8067-24-1
|